NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE127821 Query DataSets for GSE127821
Status Public on Jun 30, 2019
Title Specificity assessment of allele selective Zinc Finger Protein Repressors in hESC-derived HD neurons
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Huntington’s disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG trinucleotide expansion in the huntingtin gene (HTT), which codes for the pathologic mutant HTT (mHTT) protein. Since normal HTT is thought to be important for brain function, we engineered zinc finger protein transcription factors (ZFP-TFs) to target the pathogenic CAG repeat and selectively lower mHTT as a therapeutic strategy. Using patient-derived fibroblasts and neurons, we demonstrate that ZFP-TFs selectively repress >99% of HD-causing alleles over a wide dose range, while preserving expression of >86% of normal alleles. Other CAG-containing genes are minimally affected, and virally delivered ZFP-TFs are active and well tolerated in HD neurons beyond 100 days in culture and at least 9 months in the mouse brain. Using three HD mouse models, we demonstrate improvements in a range of molecular, histopathological, electrophysiological, and functional endpoints. Our findings support the continued development of an allele-selective ZFP-TF for the treatment of HD.
 
Overall design Four treatments (ZFP-A, ZFP-B, ZFP-C, GFP) were tested in neurons derived from HD hESCs (GENEA020). Each ZFP was tested in a different batch with the GFP control. For each batch of treatment and control, 4 replicate transfections were conducted yielding 4 biological replicates. Cells were harvested 24 hours later and processed for total RNA isolation and Affymetrix sample Prep. The same control GFP treatment was used for each batch.
 
Contributor(s) Zeitler B, Froelich S, Marlen K, Shivak DA, Yu Q, Li D, Pearl JR, Miller JC, Zhang L, Paschon DE, Hinkley SJ, Ankoudinova I, Lam S, Guschin D, Kopan L, Cherone JM, Nguyen HB, Qiao G, Ataei Y, Mendel MC, Amora R, Surosky R, Laganiere J, Vu BJ, Narayanan A, Sedaghat Y, Tillack K, Thiede C, Gärtner A, Kwak S, Bard J, Mrzljak L, Park L, Heikkinen T, Lehtimäki KK, Svedberg MM, Häggkvist J, Tari L, Tóth M, Varrone A, Halldin C, Kudwa AE, Ramboz S, Day M, Kondapalli J, Surmeier DJ, Urnov FD, Gregory PD, Rebar EJ, Munoz-Sanjuan I, Zhang HS
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Mar 04, 2019
Last update date Jul 02, 2019
Contact name Bryan Zeitler
E-mail(s) bzeitler@sangamo.com
Organization name Sangamo Therapeutics
Street address 501 Canal Blvd.
City Richmond
State/province California
ZIP/Postal code 94804
Country USA
 
Platforms (1)
GPL15207 [PrimeView] Affymetrix Human Gene Expression Array
Samples (24)
GSM3639377 Neurons 24 hr ZFPC batch1 biological rep1
GSM3639378 Neurons 24 hr ZFPC batch1 biological rep2
GSM3639379 Neurons 24 hr ZFPC batch1 biological rep3
Relations
BioProject PRJNA525455

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE127821_RAW.tar 52.4 Mb (http)(custom) TAR (of CEL, CHP)
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap